Pattern recognition receptors in equine endotoxaemia and sepsis

Equine Veterinary Journal

Volumn 44, Issue 4, 2012, Pages 490-498

  Werners, A H ^a   Bryant, C E ^b  

^a ST GEORGE S UNIVERSITY   (Grenada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endotoxaemia; Horse; Innate immunity; Pathogen recognition receptor; Pathogen associated molecular pattern; Sepsis

Indexed keywords

PATTERN RECOGNITION RECEPTOR;

ANIMAL; ANIMAL DISEASE; ENDOTOXEMIA; HORSE; HORSE DISEASE; METABOLISM; REVIEW; SEPSIS;

ANIMALS; ENDOTOXEMIA; HORSE DISEASES; HORSES; RECEPTORS, PATTERN RECOGNITION; SEPSIS;

EQUIDAE;

EID: 84862009345     PISSN: 04251644     EISSN: 20423306     Source Type: Journal    
DOI: 10.1111/j.2042-3306.2012.00574.x     Document Type: Review

References (184)

1. Roy, M.F. (2004) Sepsis in adults and foals. Vet. Clin. N. Am.: Equine Pract. 20, 41-61.
2. Lever, A. and Mackenzie, I. (2007) Sepsis: definition, epidemiology, and diagnosis. BMJ 335, 879-883.
3. Cohen, J. and Abraham, E. (1999) Microbiologic findings and correlations with serum tumor necrosis factor-α in patients with severe sepsis and septic shock. J. Infect. Dis. 180, 116-121.
4. Martin, G.S., Mannino, D.M., Eaton, S. and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554.
5. Myhre, A.E., Aasen, A.O., Thiemermann, C. and Wang, J.E. (2006) Peptidoglycan - an endotoxin in its own right? Shock 25, 227-235.
6. Sanchez, L.C. (2005) Equine neonatal sepsis. Vet. Clin. N. Am.: Equine Pract. 21, 273-293.
7. Pusterla, N., Mapes, S., Byrne, B.A. and Magdesian, K.G. (2009) Detection of bloodstream infection in neonatal foals with suspected sepsis using real-time PCR. Vet. Rec. 165, 114-117.
8. Russell, C.M., Axon, J.E., Blishen, A. and Begg, A.P. (2008) Blood culture isolates and antimicrobial sensitivities from 427 critically ill neonatal foals. Aust. Vet. J. 86, 266-271.
9. Corley, K.T.T., Pearce, G., Magdesian, K.G. and Wilson, W.D. (2007) Bacteraemia in neonatal foals: clinicopathological differences between Gram-positive and Gram-negative infections, and single organism and mixed infections. Equine Vet. J. 39, 84-89.
10. Johns, I., Tennent-Brown, B., Schaer, B.D., Southwood, L., Boston, R. and Wilkins, P. (2009) Blood culture status in mature horses with diarrhoea: a possible association with survival. Equine Vet. J. 41, 160-164.
11. Hollis, A.R., Wilkins, P.A., Palmer, J.E. and Boston, R.C. (2008) Bacteremia in equine neonatal diarrhea: a retrospective study (1990-2007). J. Vet. Intern. Med. 22, 1203-1209.
12. Monie, T.P., Bryant, C.E. and Gay, N.J. (2009) Activating immunity: lessons from the TLRs and NLRs. Trends Biochem. Sci. 34, 553-561.
13. O'Neill, L., Bryant, C. and Doyle, S. (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol. Rev. 61, 177-197.
14. Gay, N.J. and Gangloff, M. (2007) Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76, 141-165.
15. Bryant, C.E., Spring, D.R., Gangloff, M. and Gay, N.J. (2010) The molecular basis of the host response to lipopolysaccharide. Nat. Rev. Microbiol. 8, 8-14.
16. Jin, M.S., Kim, S.E., Heo, J.Y., Lee, M.E., Kim, H.M., Paik, S.G., Lee, H. and Lee, J.O. (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130, 1071-1082.
17. Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C.V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B. and Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
18. Lohmann, K.L., Vandenplas, M.L., Barton, M.H., Bryant, C.E. and Moore, J.N. (2007) The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist. J. Endotoxin Res. 13, 235-242.
19. Park, B.S., Song, D.H., Kim, H.M., Choi, B.S., Lee, H. and Lee, J.O. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191-1195.
20. Tobias, P.S., Soldau, K. and Ulevitch, R.J. (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164, 777-793.
21. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. and Mathison, J.C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
22. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K. and Kimoto, M. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782.
23. Kovach, N.L., Yee, E., Munford, R.S., Raetz, C.R. and Harlan, J.M. (1990) Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J. Exp. Med. 172, 77-84.
24. Walsh, C., Gangloff, M., Monie, T., Smyth, T., Wei, B., McKinley, T.J., Maskell, D., Gay, N. and Bryant, C. (2008) Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J. Immunol. 181, 1245-1254.
25. Vogel, S.N., Madonna, G.S., Wahl, L.M. and Rick, P.D. (1984) In vitro stimulation of C3H/HeJ spleen cells and macrophages by a lipid A precursor molecule derived from Salmonella typhimurium. J. Immunol. 132, 347-353.
26. Golenbock, D.T., Hampton, R.Y., Qureshi, N., Takayama, K. and Raetz, C.R. (1991) Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266, 19490-19498.
27. Akira, S., Uematsu, S. and Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
28. Senior, J.M., Proudman, C.J., Leuwer, M. and Carter, S.D. (2011) Plasma endotoxin in horses presented to an equine referral hospital: correlation to selected clinical parameters and outcomes. Equine Vet. J. 43, 585-591.
29. Steverink, P.J., Sturk, A., Rutten, V.P., Wagenaar-Hilbers, J.P., Klein, W.R., van der Velden, M.A. and Nemeth, F. (1995) Endotoxin, interleukin-6 and tumor necrosis factor concentrations in equine acute abdominal disease: relation to clinical outcome. J. Endotoxin Res. 2, 289-299.
30. Hunt, J.M., Edwards, G.B. and Clarke, K.W. (1986) Incidence, diagnosis and treatment of postoperative complications in colic cases. Equine Vet. J. 18, 264-270.
31. Bailey, S.R., Adair, H.S., Reinemeyer, C.R., Morgan, S.J., Brooks, A.C., Longhofer, S.L. and Elliott, J. (2009) Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis. Vet. Immunol. Immunopathol. 129, 167-173.
32. Barton, M.H., Williamson, L., Jacks, S. and Norton, N. (2003) Effects on plasma endotoxin and eicosanoid concentrations and serum cytokine activities in horses competing in a 48-, 83-, or 159-km endurance ride under similar terrain and weather conditions. Am. J. Vet. Res. 64, 754-761.
33. Barton, M.H., Morris, D.D., Norton, N. and Prasse, K.W. (1998) Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J. Vet. Intern. Med. 12, 26-35.
34. Peek, S.F., Semrad, S., McGuirk, S.M., Riseberg, A., Ann Slack, J., Marques, F., Coombs, D., Lien, L., Keuler, N. and Darien, B.J. (2006) Prognostic value of clinicopathologic variables obtained at admission and effect of antiendotoxin plasma on survival in septic and critically ill foals. J. Vet. Intern. Med. 20, 569-574.
35. Pirie, R.S., Collie, D.D.S., Dixon, P.M. and McGorum, B.C. (2003) Inhaled endotoxin and organic dust particulates have synergistic proinflammatory effects in equine heaves (organic dust-induced asthma). Clin. Exp. Allergy 33, 676-683.
36. Simonen-Jokinen, T., Pirie, R.S., McGorum, B. and Maisi, P. (2005) Dose responses to inhalation of endotoxin, hay dust suspension and Aspergillus fumigatus extract in horses as measured by levels and activation of matrix metalloproteinase-9. Equine Vet. J. 37, 155-160.
37. Berndt, A., Derksen, F.J., Venta, P.J., Ewart, S., Yuzbasiyan-Gurkan, V. and Robinson, N.E. (2007) Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L936-L943.
38. Singh Suri, S., Janardhan, K.S., Parbhakar, O., Caldwell, S., Appleyard, G. and Singh, B. (2006) Expression of toll-like receptor 4 and 2 in horse lungs. Vet. Res. 37, 541-551.
39. Kang, J.Y., Nan, X., Jin, M.S., Youn, S.J., Ryu, Y.H., Mah, S., Han, S.H., Lee, H., Paik, S.G. and Lee, J.O. (2009) Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31, 873-884.
40. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K. and Akira, S. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443-451.
41. Lorenz, E., Mira, J.P., Cornish, K.L., Arbour, N.C. and Schwartz, D.A. (2000) A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68, 6398-6401.
42. Fan, J., Frey, R.S. and Malik, A.B. (2003) TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest. 112, 1234-1243.
43. Hayashi, F., Smith, K.D., Ozinsky, A., Hawn, T.R., Yi, E.C., Goodlett, D.R., Eng, J.K., Akira, S., Underhill, D.M. and Aderem, A. (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410, 1099-1103.
44. Van Asten, F.J., Hendriks, H.G., Koninkx, J.F., Van der Zeijst, B.A. and Gaastra, W. (2000) Inactivation of the flagellin gene of Salmonella enterica serotype enteritidis strongly reduces invasion into differentiated Caco-2 cells. FEMS Microbiol. Lett. 185, 175-179.
45. Feary, D.J. and Hassel, D.M. (2006) Enteritis and colitis in horses. Vet. Clin. N. Am.: Equine Pract. 22, 437-479, ix.
46. Bell, J.K., Mullen, G.E., Leifer, C.A., Mazzoni, A., Davies, D.R. and Segal, D.M. (2003) Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol. 24, 528-533.
47. Andersen-Nissen, E., Smith, K.D., Strobe, K.L., Barrett, S.L., Cookson, B.T., Logan, S.M. and Aderem, A. (2005) Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. U.S.A. 102, 9247-9252.
48. Smith, K.D., Andersen-Nissen, E., Hayashi, F., Strobe, K., Bergman, M.A., Barrett, S.L., Cookson, B.T. and Aderem, A. (2003) Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4, 1247-1253.
49. Applequist, S.E., Wallin, R.P. and Ljunggren, H.G. (2002) Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int. Immunol. 14, 1065-1074.
50. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S. and Hartmann, G. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
51. Keestra, A.M., de Zoete, M.R., van Aubel, R.A. and van Putten, J.P. (2008) Functional characterization of chicken TLR5 reveals species-specific recognition of flagellin. Mol. Immunol. 45, 1298-1307.
52. Kwon, S., Gewirtz, A.T., Hurley, D.J., Robertson, T.P., Moore, J.N. and Vandenplas, M.L. (2011) Disparities in TLR5 expression and responsiveness to flagellin in equine neutrophils and mononuclear phagocytes. J. Immunol. 186, 6263-6270.
53. Lun, S.W., Wong, C.K., Ko, F.W., Hui, D.S. and Lam, C.W. (2009) Expression and functional analysis of toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J. Clin. Immunol. 29, 330-342.
54. Liaudet, L., Deb, A., Pacher, P., Mabley, J.G., Murthy, K.G., Salzman, A.L. and Szabo, C. (2002) The flagellin-TLR5 axis: therapeutic opportunities. Drug News Perspect. 15, 397-409.
55. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
56. Banchereau, J. and Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
57. Chen, J., Nag, S., Vidi, P.A. and Irudayaraj, J. (2011) Single molecule in vivo analysis of Toll-like receptor 9 and CpG DNA interaction. PLoS One 6, e17991.
58. Ewald, S.E., Engel, A., Lee, J., Wang, M., Bogyo, M. and Barton, G.M. (2011) Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J. Exp. Med. 208, 643-651.
59. Avalos, A.M. and Ploegh, H.L. (2011) Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9. Eur. J. Immunol. 41, 2820-2827.
60. Chuang, T.H. and Ulevitch, R.J. (2000) Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11, 372-378.
61. Franch, R., Cardazzo, B., Antonello, J., Castagnaro, M., Patarnello, T. and Bargelloni, L. (2006) Full-length sequence and expression analysis of Toll-like receptor 9 in the gilthead seabream (Sparus aurata L.). Gene 378, 42-51.
62. Yao, C.L., Kong, P., Wang, Z.Y., Ji, P.F., Cai, M.Y., Liu, X.D. and Han, X.Z. (2008) Cloning and expression analysis of two alternative splicing toll-like receptor 9 isoforms A and B in large yellow croaker, Pseudosciaena crocea. Fish Shellfish Immunol. 25, 648-656.
63. McKelvey, K.J., Highton, J. and Hessian, P.A. (2011) Cell-specific expression of TLR9 isoforms in inflammation. J. Autoimmun. 36, 76-86.
64. Schneberger, D., Caldwell, S., Suri, S.S. and Singh, B. (2009) Expression of toll-like receptor 9 in horse lungs. Anat. Rec. (Hoboken) 292, 1068-1077.
65. Zhang, Y.W., Davis, E.G., Blecha, F. and Wilkerson, M.J. (2008) Molecular cloning and characterization of equine Toll-like receptor 9. Vet. Immunol. Immunopathol. 124, 209-219.
66. Gornik, K., Moore, P. and Figueiredo, M. (2011) Expression of Toll-like receptors 2, 3, 4, 6, 9, and MD-2 in the normal equine cornea, limbus, and conjunctiva. Vet. Ophthalmol. 14, 80-85.
67. Liu, M., Liu, T., Bordin, A., Nerren, J. and Cohen, N. (2009) Activation of foal neutrophils at different ages by CpG oligodeoxynucleotides and Rhodococcus equi. Cytokine 48, 280-289.
68. Flaminio, M.J.B., Borges, A.S., Nydam, D.V., Horohov, D.W., Hecker, R. and Matychak, M.B. (2007) The effect of CpG-ODN on antigen presenting cells of the foal. J. Immune Based Ther. Vaccines 5, 1.
69. Rietdijk, S.T., Burwell, T., Bertin, J. and Coyle, A.J. (2008) Sensing intracellular pathogens - NOD-like receptors. Curr. Opin. Pharmacol. 8, 261-266.
70. Horvath, G.L., Schrum, J.E., De Nardo, C.M. and Latz, E. (2011) Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol. Rev. 243, 119-135.
71. Martinon, F., Burns, K. and Tschopp, J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426.
72. Girardin, S.E., Boneca, I.G., Carneiro, L.A., Antignac, A., Jéhanno, M., Viala, J., Tedin, K., Taha, M.K., Labigne, A., Zähringer, U., Coyle, A.J., DiStefano, P.S., Bertin, J., Sansonetti, P.J. and Philpott, D.J. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584-1587.
73. Kanneganti, T.D., Lamkanfi, M. and Núñez, G. (2007) Intracellular NOD-like receptors in host defense and disease. Immunity 27, 549-559.
74. Ogura, Y., Inohara, N., Benito, A., Chen, F.F., Yamaoka, S. and Nunez, G. (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276, 4812-4818.
75. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M.A., Foster, S.J., Mak, T.W., Nuñez, G. and Inohara, N. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4, 702-707.
76. Clarke, T.B., Davis, K.M., Lysenko, E.S., Zhou, A.Y., Yu, Y. and Weiser, J.N. (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16, 228-231.
77. Racine, J., Gerber, V., Miskovic Feutz, M., Riley, C.P., Adamec, J., Swinburne, J.E. and Couetil, L.L. (2011) Comparison of genomic and proteomic data in recurrent airway obstruction affected horses using ingenuity pathway analysis®. BMC Vet. Res. 7, 48.
78. Sutterwala, F.S. and Flavell, R. (2009) NLRC4/IPAF: a CARD carrying member of the NLR family. Clin. Immunol. 130, 2-6.
79. Poyet, J.L., Srinivasula, S.M., Tnani, M., Razmara, M., Fernandes-Alnemri, T. and Alnemri, E.S. (2001) Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 276, 28309-28313.
80. Mariathasan, S., Newton, K., Monack, D.M., Vucic, D., French, D.M., Lee, W.P., Roose-Girma, M., Erickson, S. and Dixit, V. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218.
81. Miao, E.A., Ernst, R.K., Dors, M., Mao, D.P. and Aderem, A. (2008) Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc. Natl. Acad. Sci. U.S.A. 105, 2562-2567.
82. Hilbi, H., Moss, J.E., Hersh, D., Chen, Y., Arondel, J., Banerjee, S., Flavell, R., Yuan, J., Sansonetti, P.J. and Zychlinsky, A. (1998) Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273, 32895-32900.
83. Amer, A., Franchi, L., Kanneganti, T.D., Body-Malapel, M., Özören, N., Brady, G., Meshinchi, S., Jagirdar, R., Gewirtz, A., Akira, S. and Núñez, G. (2006) Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J. Biol. Chem. 281, 35217-35223.
84. Miao, E.A., Alpuche-Aranda, C.M., Dors, M., Clark, A.E., Bader, M.W., Miller, S.I. and Aderem, A. (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7, 569-575.
85. Franchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., Grant, E.P. and Núñez, G. (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7, 576-582.
86. Miao, E.A., Mao, D.P., Yudkovsky, N., Bonneau, R., Lorang, C.G., Warren, S.E., Leaf, I.A. and Aderem, A. (2010) Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 107, 3076-3080.
87. Craven, R.R., Gao, X., Allen, I.C., Gris, D., Bubeck Wardenburg, J., McElvania-Tekippe, E., Ting, J.P. and Duncan, J.A. (2009) Staphylococcus aureus α-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 4, e7446.
88. McNeela, E.A., Burke, A., Neill, D.R., Baxter, C., Fernandes, V.E., Ferreira, D., Smeaton, S., El-Rachkidy, R., McLoughlin, R.M., Mori, A., Moran, B., Fitzgerald, K.A., Tschopp, J., Petrilli, V., Andrew, P.W., Kadioglu, A. and Lavelle, E. (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6, e1001191.
89. Broz, P., Newton, K., Lamkanfi, M., Mariathasan, S., Dixit, V.M. and Monack, D.M. (2010) Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207, 1745-1755.
90. Bryant, C. and Fitzgerald, K.A. (2009) Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 19, 455-464.
91. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., Latz, E. and Fitzgerald, K. (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518.
92. Burckstummer, T., Baumann, C., Bluml, S., Dixit, E., Durnberger, G., Jahn, H., Planyavsky, M., Bilban, M., Colinge, J., Bennett, K.L. and Superti-Furga, G. (2009) An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10, 266-272.
93. Choubey, D., Walter, S., Geng, Y. and Xin, H. (2000) Cytoplasmic localization of the interferon-inducible protein that is encoded by the AIM2 (absent in melanoma) gene from the 200-gene family. FEBS Lett. 474, 38-42.
94. Rathinam, V.A.K., Jiang, Z., Waggoner, S.N., Sharma, S., Cole, L.E., Waggoner, L., Vanaja, S.K., Monks, B.G., Ganesan, S., Latz, E., Hornung, V., Vogel, S.N., Szomolanyi-Tsuda, E. and Fitzgerald, K. (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. 11, 395-402.
95. Warren, S.E., Armstrong, A., Hamilton, M.K., Mao, D.P., Leaf, I., Miao, E. and Aderem, A. (2010) Cutting edge: cytosolic bacterial DNA activates the inflammasome via Aim2. J. Immunol. 185, 818-821.
96. Lien, E., Means, T.K., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K., Fenton, M.J., Oikawa, M., Qureshi, N., Monks, B., Finberg, R.W., Ingalls, R.R. and Golenbock, D.T. (2000) Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105, 497-504.
97. Lohmann, K.L., Vandenplas, M., Barton, M.H. and Moore, J.N. (2003) Lipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells. J. Endotoxin Res. 9, 33-37.
98. Bryant, C.E., Ouellette, A., Lohmann, K., Vandenplas, M., Moore, J.N., Maskell, D.J. and Farnfield, B.A. (2007) The cellular Toll-like receptor 4 antagonist E5531 can act as an agonist in horse whole blood. Vet. Immunol. Immunopathol. 116, 182-189.
99. Bunnell, E., Lynn, M., Habet, K., Neumann, A., Perdomo, C.A., Friedhoff, L.T., Rogers, S.L. and Parrillo, J.E. (2000) A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia. Crit. Care Med. 28, 2713-2720.
100. Kawata, T., Bristol, J.R., Rossignol, D.P., Rose, J.R., Kobayashi, S., Yokohama, H., Ishibashi, A., Christ, W.J., Katayama, K., Yamatsu, I. and Kishi, Y. (1999) E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide. Br. J. Pharmacol. 127, 853-862.
101. Rossignol, D.P. and Lynn, M. (2002) Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue. J. Endotoxin Res. 8, 483-488.
102. Lynn, M., Wong, Y.N., Wheeler, J.L., Kao, R.J., Perdomo, C.A., Noveck, R., Vargas, R., D'Angelo, T., Gotzkowsky, S., McMahon, F.G., Wasan, K.M. and Rossignol, D.P. (2004) Extended in vivo pharmacodynamic activity of E5564 in normal volunteers with experimental endotoxemia [corrected]. J. Pharmacol. Exp. Ther. 308, 175-181.
103. Figueiredo, M.D., Moore, J.N., Vandenplas, M.L., Sun, W. and Murray, T.F. (2008) Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes. Am. J. Vet. Res. 69, 796-803.
104. Kalil, A.C., LaRosa, S.P., Gogate, J., Lynn, M. and Opal, S.M. (2011) Influence of severity of illness on the effects of eritoran tetrasodium (E5564) and on other therapies for severe sepsis. Shock 36, 327-331.
105. Opal, S.M. (2011) Eritoran trial reaches unfortunate conclusion. In: ISICEM News, Ed: L. Davenport, MediFore Limited, Brussels. pp 8-9.
106. Hennessy, E.J., Parker, A.E. and O'Neill, L.A. (2010) Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9, 293-307.
107. Spyvee, M.R., Zhang, H., Hawkins, L.D. and Chow, J.C. (2005) Toll-like receptor 2 antagonists. Part 1: preliminary SAR investigation of novel synthetic phospholipids. Bioorg. Med. Chem. Lett. 15, 5494-5498.
108. Meng, G., Rutz, M., Schiemann, M., Metzger, J., Grabiec, A., Schwandner, R., Luppa, P.B., Ebel, F., Busch, D.H., Bauer, S., Wagner, H. and Kirschning, C.J. (2004) Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J. Clin. Invest. 113, 1473-1481.
109. Kirschning, C.J., Dreher, S., Maass, B., Fichte, S., Schade, J., Koster, M., Noack, A., Lindenmaier, W., Wagner, H. and Boldicke, T. (2010) Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation. BMC Biotechnol. 10, 31.
110. Nic An Ultaigh, S., Saber, T.P., McCormick, J., Connolly, M., Dellacasagrande, J., Keogh, B., McCormack, W., Reilly, M., O'Neill, L.A., McGuirk, P., Fearon, U. and Veale, D.J. (2011) Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res. Ther. 13, R33.
111. Arslan, F., Smeets, M.B., O'Neill, L.A., Keogh, B., McGuirk, P., Timmers, L., Tersteeg, C., Hoefer, I.E., Doevendans, P.A., Pasterkamp, G. and de Kleijn, D.P. (2010) Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121, 80-90.
112. Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R.L. and Akira, S. (2002) Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14.
113. Kwon, S., Vandenplas, M.L., Figueiredo, M.D., Salter, C.E., Andrietti, A.L., Robertson, T.P., Moore, J.N. and Hurley, D.J. (2010) Differential induction of Toll-like receptor gene expression in equine monocytes activated by Toll-like receptor ligands or TNF-α. Vet. Immunol. Immunopathol. 138, 213-217.
114. Alexopoulou, L., Thomas, V., Schnare, M., Lobet, Y., Anguita, J., Schoen, R.T., Medzhitov, R., Fikrig, E. and Flavell, R.A. (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8, 878-884.
115. Wyllie, D.H., Kiss-Toth, E., Visintin, A., Smith, S.C., Boussouf, S., Segal, D.M., Duff, G.W. and Dower, S.K. (2000) Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J. Immunol. 165, 7125-7132.
116. Massari, P., Henneke, P., Ho, Y., Latz, E., Golenbock, D.T. and Wetzler, L.M. (2002) Cutting edge: immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168, 1533-1537.
117. Aliprantis, A.O., Yang, R.B., Mark, M.R., Suggett, S., Devaux, B., Radolf, J.D., Klimpel, G.R., Godowski, P. and Zychlinsky, A. (1999) Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739.
118. Brightbill, H.D., Libraty, D.H., Krutzik, S.R., Yang, R.B., Belisle, J.T., Bleharski, J.R., Maitland, M., Norgard, M.V., Plevy, S.E., Smale, S.T., Brennan, P.J., Bloom, B.R., Godowski, P.J. and Modlin, R.L. (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732-736.
119. Opitz, B., Schröder, N.W., Spreitzer, I., Michelsen, K.S., Kirschning, C.J., Hallatschek, W., Zähringer, U., Hartung, T., Göbel, U.B. and Schumann, R.R. (2001) Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J. Biol. Chem. 276, 22041-22047.
120. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M. and Kirschning, C.J. (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274, 17406-17409.
121. Underhill, D.M., Ozinsky, A., Smith, K.D. and Aderem, A. (1999) Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. U.S.A. 96, 14459-14463.
122. Garton, N.J., Gilleron, M., Brando, T., Dan, H.H., Giguere, S., Puzo, G., Prescott, J.F. and Sutcliffe, I.C. (2002) A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J. Biol. Chem. 277, 31722-31733.
123. Codolo, G., Papinutto, E., Polenghi, A., D'Elios, M.M., Zanotti, G. and de Bernard, M. (2010) Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi. Biochim. Biophys. Acta 1804, 2191-2197.
124. Campos, M.A., Almeida, I.C., Takeuchi, O., Akira, S., Valente, E.P., Procopio, D.O., Travassos, L.R., Smith, J.A., Golenbock, D.T. and Gazzinelli, R.T. (2001) Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167, 416-423.
125. Hajjar, A.M., O'Mahony, D.S., Ozinsky, A., Underhill, D.M., Aderem, A., Klebanoff, S.J. and Wilson, C.B. (2001) Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166, 15-19.
126. Ozinsky, A., Underhill, D.M., Fontenot, J.D., Hajjar, A.M., Smith, K.D., Wilson, C.B., Schroeder, L. and Aderem, A. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 13766-13771.
127. Jouault, T., Ibata-Ombetta, S., Takeuchi, O., Trinel, P.A., Sacchetti, P., Lefebvre, P., Akira, S. and Poulain, D. (2003) Candida albicans phospholipomannan is sensed through toll-like receptors. J. Infect. Dis. 188, 165-172.
128. Werts, C., Tapping, R.I., Mathison, J.C., Chuang, T.H., Kravchenko, V., Saint Girons, I., Haake, D.A., Godowski, P.J., Hayashi, F., Ozinsky, A., Underhill, D.M., Kirschning, C.J., Wagner, H., Aderem, A., Tobias, P.S. and Ulevitch, R.J. (2001) Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2, 346-352.
129. Hirschfeld, M., Weis, J.J., Toshchakov, V., Salkowski, C.A., Cody, M.J., Ward, D.C., Qureshi, N., Michalek, S.M. and Vogel, S.N. (2001) Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69, 1477-1482.
130. Vabulas, R.M., Ahmad-Nejad, P., da Costa, C., Miethke, T., Kirschning, C.J., Hacker, H. and Wagner, H. (2001) Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276, 31332-31339.
131. Asea, A., Rehli, M., Kabingu, E., Boch, J.A., Bare, O., Auron, P.E., Stevenson, M.A. and Calderwood, S.K. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277, 15028-15034.
132. Huang, Q.Q., Sobkoviak, R., Jockheck-Clark, A.R., Shi, B., Mandelin, A.M., 2nd, Tak, P.P., Haines, G.K., 3rd, Nicchitta, C.V. and Pope, R.M. (2009) Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J. Immunol. 182, 4965-4973.
133. Yu, M., Wang, H., Ding, A., Golenbock, D.T., Latz, E., Czura, C.J., Fenton, M.J., Tracey, K.J. and Yang, H. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26, 174-179.
134. Scheibner, K.A., Lutz, M.A., Boodoo, S., Fenton, M.J., Powell, J.D. and Horton, M.R. (2006) Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281.
135. Gariboldi, S., Palazzo, M., Zanobbio, L., Selleri, S., Sommariva, M., Sfondrini, L., Cavicchini, S., Balsari, A. and Rumio, C. (2008) Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of β-defensin 2 via TLR2 and TLR4. J. Immunol. 181, 2103-2110.
136. Bieback, K., Lien, E., Klagge, I.M., Avota, E., Schneider-Schaulies, J., Duprex, W.P., Wagner, H., Kirschning, C.J., Ter Meulen, V. and Schneider-Schaulies, S. (2002) Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76, 8729-8736.
137. Kurt-Jones, E.A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M.M., Knipe, D.M. and Finberg, R.W. (2004) Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U.S.A. 101, 1315-1320.
138. Compton, T., Kurt-Jones, E.A., Boehme, K.W., Belko, J., Latz, E., Golenbock, D.T. and Finberg, R.W. (2003) Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77, 4588-4596.
139. Murawski, M.R., Bowen, G.N., Cerny, A.M., Anderson, L.J., Haynes, L.M., Tripp, R.A., Kurt-Jones, E.A. and Finberg, R.W. (2009) Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol. 83, 1492-1500.
140. Zhou, S., Kurt-Jones, E.A., Mandell, L., Cerny, A., Chan, M., Golenbock, D.T. and Finberg, R.W. (2005) MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 35, 822-830.
141. Jeannin, P., Bottazzi, B., Sironi, M., Doni, A., Rusnati, M., Presta, M., Maina, V., Magistrelli, G., Haeuw, J.F., Hoeffel, G., Thieblemont, N., Corvaia, N., Garlanda, C., Delneste, Y. and Mantovani, A. (2005) Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22, 551-560.
142. Flo, T.H., Halaas, O., Lien, E., Ryan, L., Teti, G., Golenbock, D.T., Sundan, A. and Espevik, T. (2000) Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164, 2064-2069.
143. Dosch, S.F., Mahajan, S.D. and Collins, A.R. (2009) SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro. Virus Res. 142, 19-27.
144. Tada, H., Nemoto, E., Shimauchi, H., Watanabe, T., Mikami, T., Matsumoto, T., Ohno, N., Tamura, H., Shibata, K., Akashi, S., Miyake, K., Sugawara, S. and Takada, H. (2002) Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol. Immunol. 46, 503-512.
145. Shoham, S., Huang, C., Chen, J.M., Golenbock, D.T. and Levitz, S.M. (2001) Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166, 4620-4626.
146. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C. and Simon, J. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195, 99-111.
147. Gaddis, D.E., Michalek, S.M. and Katz, J. (2009) Requirement of TLR4 and CD14 in dendritic cell activation by Hemagglutinin B from Porphyromonas gingivalis. Mol. Immunol. 46, 2493-2504.
148. Gomi, K., Kawasaki, K., Kawai, Y., Shiozaki, M. and Nishijima, M. (2002) Toll-like receptor 4-MD-2 complex mediates the signal transduction induced by flavolipin, an amino acid-containing lipid unique to Flavobacterium meningosepticum. J. Immunol. 168, 2939-2943.
149. Morefield, G.L., Hawkins, L.D., Ishizaka, S.T., Kissner, T.L. and Ulrich, R.G. (2007) Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome. Clin. Vaccine Immunol. 14, 1499-1504.
150. Kawasaki, K., Akashi, S., Shimazu, R., Yoshida, T., Miyake, K. and Nishijima, M. (2000) Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J. Biol. Chem. 275, 2251-2254.
151. Kurt-Jones, E.A., Popova, L., Kwinn, L., Haynes, L.M., Jones, L.P., Tripp, R.A., Walsh, E.E., Freeman, M.W., Golenbock, D.T., Anderson, L.J. and Finberg, R.W. (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1, 398-401.
152. Rassa, J.C., Meyers, J.L., Zhang, Y., Kudaravalli, R. and Ross, S.R. (2002) Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U.S.A. 99, 2281-2286.
153. Okamura, Y., Watari, M., Jerud, E.S., Young, D.W., Ishizaka, S.T., Rose, J., Chow, J.C. and Strauss, J.F., 3rd (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233.
154. Johnson, G.B., Brunn, G.J., Kodaira, Y. and Platt, J.L. (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168, 5233-5239.
155. Smiley, S.T., King, J.A. and Hancock, W.W. (2001) Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167, 2887-2894.
156. Roelofs, M.F., Boelens, W.C., Joosten, L.A., Abdollahi-Roodsaz, S., Geurts, J., Wunderink, L.U., Schreurs, B.W., van den Berg, W.B. and Radstake, T.R. (2006) Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J. Immunol. 176, 7021-7027.
157. Biragyn, A., Ruffini, P.A., Leifer, C.A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A.K., Farber, J.M., Segal, D.M., Oppenheim, J.J. and Kwak, L.W. (2002) Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298, 1025-1029.
158. Eaves-Pyles, T.D., Wong, H.R., Odoms, K. and Pyles, R.B. (2001) Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein. J. Immunol. 167, 7009-7016.
159. Takeuchi, O., Kawai, T., Muhlradt, P.F., Morr, M., Radolf, J.D., Zychlinsky, A., Takeda, K. and Akira, S. (2001) Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13, 933-940.
160. Henneke, P., Takeuchi, O., van Strijp, J.A., Guttormsen, H.K., Smith, J.A., Schromm, A.B., Espevik, T.A., Akira, S., Nizet, V., Kasper, D.L. and Golenbock, D.T. (2001) Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J. Immunol. 167, 7069-7076.
161. Lund, J., Sato, A., Akira, S., Medzhitov, R. and Iwasaki, A. (2003) Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520.
162. Akira, S. and Hemmi, H. (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85, 85-95.
163. Leadbetter, E.A., Rifkin, I.R., Hohlbaum, A.M., Beaudette, B.C., Shlomchik, M.J. and Marshak-Rothstein, A. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607.
164. Coban, C., Ishii, K.J., Kawai, T., Hemmi, H., Sato, S., Uematsu, S., Yamamoto, M., Takeuchi, O., Itagaki, S., Kumar, N., Horii, T. and Akira, S. (2005) Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201, 19-25.
165. Girardin, S.E., Travassos, L.H., Hervé, M., Blanot, D., Boneca, I.G., Philpott, D.J., Sansonetti, P.J. and Mengin-Lecreulx, D. (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278, 41702-41708.
166. Tada, H., Aiba, S., Shibata, K., Ohteki, T. and Takada, H. (2005) Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73, 7967-7976.
167. Rajan, J.V., Rodriguez, D., Miao, E.A. and Aderem, A. (2011) The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J. Virol. 85, 4167-4172.
168. Allen, I.C., Scull, M.A., Moore, C.B., Holl, E.K., McElvania-TeKippe, E., Taxman, D.J., Guthrie, E.H., Pickles, R.J. and Ting, J.P. (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30, 556-565.
169. Hise, A.G., Tomalka, J., Ganesan, S., Patel, K., Hall, B.A., Brown, G.D. and Fitzgerald, K.A. (2009) An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5, 487-497.
170. Said-Sadier, N., Padilla, E., Langsley, G. and Ojcius, D.M. (2010) Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS One 5, e10008.
171. Kumar, H., Kumagai, Y., Tsuchida, T., Koenig, P.A., Satoh, T., Guo, Z., Jang, M.H., Saitoh, T., Akira, S. and Kawai, T. (2009) Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal β-glucan. J. Immunol. 183, 8061-8067.
172. Martinon, F., Agostini, L., Meylan, E. and Tschopp, J. (2004) Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14, 1929-1934.
173. Mariathasan, S., Weiss, D.S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W.P., Weinrauch, Y., Monack, D.M. and Dixit, V.M. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232.
174. Walev, I., Reske, K., Palmer, M., Valeva, A. and Bhakdi, S. (1995) Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J. 14, 1607-1614.
175. Gurcel, L., Abrami, L., Girardin, S., Tschopp, J. and van der Goot, F.G. (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135-1145.
176. Dostert, C., Guarda, G., Romero, J.F., Menu, P., Gross, O., Tardivel, A., Suva, M.L., Stehle, J.C., Kopf, M., Stamenkovic, I., Corradin, G. and Tschopp, J. (2009) Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 4, e6510.
177. Warren, S.E., Mao, D.P., Rodriguez, A.E., Miao, E.A. and Aderem, A. (2008) Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J. Immunol. 180, 7558-7564.
178. Kanneganti, T.D., Body-Malapel, M., Amer, A., Park, J.H., Whitfield, J., Franchi, L., Taraporewala, Z.F., Miller, D., Patton, J.T., Inohara, N. and Núñez, G. (2006) Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281, 36560-36568.
179. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. and Tschopp, J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241.
180. Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T. and Tschopp, J. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677.
181. Kool, M., Petrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I.M., Castillo, R., Lambrecht, B.N. and Tschopp, J. (2008) Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181, 3755-3759.
182. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J. and Golenbock, D.T. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9, 857-865.
183. Tomalka, J., Ganesan, S., Azodi, E., Patel, K., Majmudar, P., Hall, B.A., Fitzgerald, K.A. and Hise, A.G. (2011) A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog. 7, e1002379.
184. Suzuki, T., Franchi, L., Toma, C., Ashida, H., Ogawa, M., Yoshikawa, Y., Mimuro, H., Inohara, N., Sasakawa, C. and Nunez, G. (2007) Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 3, e111.